Skystar Bio-Pharmaceutical Co (FRA:GNJC) Additional Paid-In Capital : €32.50 Mil(As of Sep. 2014)

View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Additional Paid-In Capital?

Skystar Bio-Pharmaceutical Co's quarterly additional paid-in capital increased from Mar. 2014 (€27.25 Mil) to Jun. 2014 (€27.81 Mil) and increased from Jun. 2014 (€27.81 Mil) to Sep. 2014 (€32.50 Mil).

Skystar Bio-Pharmaceutical Co's annual additional paid-in capital increased from Dec. 2011 (€27.20 Mil) to Dec. 2012 (€28.21 Mil) but then declined from Dec. 2012 (€28.21 Mil) to Dec. 2013 (€27.47 Mil).

Skystar Bio-Pharmaceutical Co Additional Paid-In Capital Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Additional Paid-In Capital Chart

Skystar Bio-Pharmaceutical Co Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Additional Paid-In Capital

Get a 7-Day Free Trial

23.72

27.05

27.20

28.21

27.47

Skystar Bio-Pharmaceutical Co Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Additional Paid-In Capital	Get a 7-Day Free Trial															27.69	27.47	27.25	27.81	32.50

Skystar Bio-Pharmaceutical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Skystar Bio-Pharmaceutical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (FRA:GNJC) » Definitions » Additional Paid-In Capital

Traded in Other Exchanges

N/A

Address

No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN

Website

http://www.skystarbio-pharmaceutical.com

Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Headlines

No Headlines